(Q47861024)

English

New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: Mechanistic and pharmacological implications

scientific article published on 21 February 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/18294965

New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: Mechanistic and pharmacological implications (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/18294965

0 references

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/18294965

Chiara Gabbiani

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/18294965

Anna Rita Bilia

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/18294965

object named as

Luigi Messori

4

0 references

author name string

Anna Rosa Sannella

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/18294965

Francesco Franco Vincieri

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/18294965

Giancarlo Majori

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/18294965

Carlo Severini

8

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/18294965

language of work or name

0 references

publication date

21 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/18294965

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/18294965

582

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/18294965

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/18294965

844-847

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/18294965

Gold-based therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

Chrysotherapy: a synoptic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

Inhibition of lysosomal cysteine proteases by chrysotherapeutic compounds: a possible mechanism for the antiarthritic activity of Au(I).

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

Effects of disease-modifying anti-rheumatic drugs (DMARDs) on the activities of rheumatoid arthritis-associated cathepsins K and S

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

Induction of mitochondrial permeability transition by auranofin, a gold(I)-phosphine derivative

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

Thioredoxin reductase as a pathophysiological factor and drug target

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

The thiol-based redox networks of pathogens: unexploited targets in the search for new drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

Thioredoxin networks in the malarial parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

Metal complexes as chemotherapeutic agents against tropical diseases: trypanosomiasis, malaria and leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

Lactate dehydrogenase and the diagnosis of malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

A medicinal chemistry perspective on artemisinin and related endoperoxides

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

A Method for Testing for Synergy with Any Number of Agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

Antimalarial drug synergism and antagonism: mechanistic and clinical significance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

New uses for old drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.02.028

21 January 2018

Identifiers

10.1016/J.FEBSLET.2008.02.028

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/18294965

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/18294965

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47861024&oldid=2173008589"